Presentation is loading. Please wait.

Presentation is loading. Please wait.

Inhibition of NAMPT using the potent inhibitor FK866 sensitizes additional tumour cells to olaparib.A‐E.Sensitivity of the cell lines MDAMB468 (A), SUM149.

Similar presentations


Presentation on theme: "Inhibition of NAMPT using the potent inhibitor FK866 sensitizes additional tumour cells to olaparib.A‐E.Sensitivity of the cell lines MDAMB468 (A), SUM149."— Presentation transcript:

1 Inhibition of NAMPT using the potent inhibitor FK866 sensitizes additional tumour cells to olaparib.A‐E.Sensitivity of the cell lines MDAMB468 (A), SUM149 (B), MDAMB231 (C), HS578T (D) and BT20 (E) was assessed as in Fig 3.F.Inhibition of NAMPT using the potent inhibitor FK866 sensitizes DLD1 BRCA2−/− tumour cells to olaparib. Inhibition of NAMPT using the potent inhibitor FK866 sensitizes additional tumour cells to olaparib.A‐E.Sensitivity of the cell lines MDAMB468 (A), SUM149 (B), MDAMB231 (C), HS578T (D) and BT20 (E) was assessed as in Fig 3.F.Inhibition of NAMPT using the potent inhibitor FK866 sensitizes DLD1 BRCA2−/− tumour cells to olaparib. Viability was measured after 14 days of continuous exposure to FK866/olaparib. Error bars represent the SEM from three independent experiments. ANOVA analysis tables are shown in Supporting Information Table S4. Ilirjana Bajrami et al. EMBO Mol Med. 2012;4: © as stated in the article, figure or figure legend


Download ppt "Inhibition of NAMPT using the potent inhibitor FK866 sensitizes additional tumour cells to olaparib.A‐E.Sensitivity of the cell lines MDAMB468 (A), SUM149."

Similar presentations


Ads by Google